95.3 MNC21h
FDA approves Eli Lilly’s new eczema treatment, Ebglyss
The U.S. Food and Drug Administration has approved Indianapolis-based Eli Lilly's new treatment for moderate to severe eczema ...
STAT2d
How I fought Big Pharma on insulin prices — and won
Collaboration between giant pharmaceutical corporations and patients with very little power just doesn’t work, according to ...
How Novartis plans to thrive without competing directly with Eli Lilly in weight loss drug market
Novartis says it's not interested in joining weight-loss drugs frenzy. CEO Vas Narasimhan explained why today on CNBC's "Squawk Box Europe".
WIBC5d
FDA Approves Eli Lilly Treatment for Eczema
INDIANAPOLIS–The U.S. Food and Drug Administration has approved Eli Lilly’s new treatment for moderate to severe eczema. It’s ...
Taiwan News6d
Latin America Insulin Market Outlook: $2.85 Billion in 2022 to $3.85 Billion by 2031
Latin America Insulin Market was valued at US$ 2,855.1 million in 2022 and is projected to attain a valuation of US$ 3,857.50 million by 2031 at a CAGR of 3.4% During the Forecast Period 2023–2031.
FiercePharma6d
Lilly's immunology unit scores another FDA nod with eczema treatment Ebglyss
Three years after establishing an immunology unit, Eli Lilly has gained its third FDA approval in the specialty area as the U ...